BioLine Rx Ltd (STU:YP2) Stock News, Headlines & Updates
BioLine Rx Ltd Stock News from GuruFocus
- 1
Jun 17, 2025
BioLine Rx (BLRX): Analyst Reiterates Buy Rating and Maintains Price Target | BLRX Stock News
GuruFocus News • 6:32am
May 30, 2025
BioLine Rx (BLRX) Upgraded to Buy by Jones Trading | BLRX Stock News
GuruFocus News • 8:31am
BioLineRx (BLRX) Receives Upgrade Amid Positive Cancer Trial Results | BLRX Stock News
GuruFocus News • 8:01am
BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting
PRNewswire • 7:00am
BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting | BLRX Stock News
GuruFocus News • 6:16am
BioLineRx (BLRX) Shares Promising Phase 2 Trial Data at ASCO 2025 | BLRX Stock News
GuruFocus News • 6:16am
May 28, 2025
BioLine Rx (BLRX) Receives Reiterated 'Buy' Rating from HC Wainwright & Co. | BLRX Stock News
GuruFocus News • 6:30am
BioLine Rx Ltd (BLRX) Q1 2025 Earnings Call Highlights: Transformational Moves and Financial Resilience
GuruFocus News • 1:04am
Q1 2025 BioLine RX Ltd Earnings Call Transcript
GuruFocus News • 11:01pm
May 27, 2025
BioLineRx (BLRX) Reports Flat EPS and Revenue Shortfall
GuruFocus News • 7:55am
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update
PRNewswire • 7:00am
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update | BLRX Stock News
GuruFocus News • 6:18am
BioLineRx (BLRX) Reports Sharp Drop in Q1 Revenue Amid Strategic Shift | BLRX Stock News
GuruFocus News • 6:15am
May 20, 2025
BioLineRx to Report First Quarter 2025 Results on May 27, 2025
PRNewswire • 7:00am
BioLineRx to Report First Quarter 2025 Results on May 27, 2025 | BLRX Stock News
GuruFocus News • 6:21am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news